Clinical Report: Broadening the Phenotypic Range of Xq28 Duplications
Overview
This report describes a family with X-linked intellectual disability (XLID) due to Xq28 duplications, highlighting significant intrafamilial phenotypic variability. The findings underscore the importance of recognizing Xq28 duplications in the differential diagnosis of XLID, particularly when accompanied by neurological impairments.
Background
X-linked intellectual disability (XLID) is a significant contributor to neurodevelopmental disorders, with X-chromosomal gene variants accounting for a notable percentage of cases in males. The Xq28 duplication syndrome, involving multiple dosage-sensitive genes, presents a complex clinical picture influenced by sex and X-chromosome inactivation patterns. Understanding this condition is crucial for accurate diagnosis and management of affected individuals and their families.
Data Highlights
No numerical data or trial data presented in the article.
Key Findings
Three affected individuals from a single family exhibited marked phenotypic variability due to Xq28 duplications.
Two male siblings presented with severe intellectual disability, speech impairment, and other neurological issues.
Their mother showed mild intellectual disability and skin manifestations, indicating variable expressivity.
Family history suggested additional affected male relatives with similar or more severe presentations.
The duplication of genes within the Xq28 region likely contributes to the multisystem involvement observed.
Clinical Implications
Healthcare professionals should consider Xq28 duplications in the differential diagnosis of XLID, especially in cases with additional neurological impairments. Genetic counseling may be beneficial for families to understand the implications of these duplications and the potential for variable expressivity among family members.
Conclusion
Xq28 duplication syndrome exemplifies the complexity of genetic contributions to neurodevelopmental disorders, highlighting the need for comprehensive genetic evaluation in affected families.
